Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 7, 1998

View Archived Issues

Trinity Biotech Acquires Selfcare Line For US$4.5M

Gemini, Chiroscience Group Partner For Obesity Genes

Canada's NRC Joining Effort To Oversee Genomics Research

Challenge To Monsanto Quashed In High Court

Mutated-Gene Culprit That Causes Duncan Disease Located By Researchers

Elan Aiming At Oncology In $130M Deal With Ligand

Oxagen Enters Astra Deal For Atherosclerosis Genes

Oxford Biomedica Signs Pair Of Research Deals

UCL Spin-Out Inpharmatica Blends Computers, Genomics

Prolifix Ousts CEO Lewis After Less Than One Year

European Confusion Deepens In Controversy Over GMOs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...